Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults (LENGTH-FATIG)

27 novembre 2017 aggiornato da: University Hospital, Clermont-Ferrand

Potential factors involved in neuromuscular fatigue were classified into two categories: 1) central factors involving the central nervous system and neural pathways, and 2) peripheral factors occurring within the muscle beyond the neuromuscular junction. In adults, it has been shown that peripheral factors contribute to a large part of the fatigue induced by repeated maximal contractions. However in children, central factors could account for the development of fatigue to a greater extent. Force-generating capacity and musculotendinous stiffness could be two of the discriminatory factors accounting for the differences in the neuromuscular fatigue between children and adults.

Force production capacity and musculotendinous stiffness vary as function of muscle length. Naturally, they could differ depending on the muscle groups studied. The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults. The investigators formulated the hypotheses that at short muscle length force and low musculotendinous stiffness, differences in force between children and adults would be reduced. Thus neuromuscular fatigue development and aetiology would be similar between both groups. The results of the present protocol will allow to better understanding of the aetiology of neuromuscular fatigue in children and help improving training or rehabilitation programs.

Panoramica dello studio

Stato

Completato

Intervento / Trattamento

Descrizione dettagliata

The study of neuromuscular fatigue in children is a recently topic in the field of sport sciences. Such knowledge could improve the efficiency and security of training and rehabilitation in healthy children and children with diseases like obesity.

The LENGTH-FATIG study will provide knowledge about the peripheral and central mechanisms of the neuromuscular fatigue in children and adults. Fatigue will test for different muscle groups (knee extensors and ankle plantar flexors) at different muscle lengths (short, optimal and long).

During high-intensity exercise, prepubertal children are more resistant to fatigue than adults. Contributions of the central and peripheral components to the development of neuromuscular fatigue are also different between both populations. The reduced children's fatigue coud be particularly related to a lower peripheral (i.e. muscular) fatigue. This might be attributed to the fact that prepubertal children rely more on oxidative than anaerobic metabolism than adults during fatiguing exercise. On the other hand, nervous factors could also explain differences in fatigue between children and adults. However, this topic is scarcely documented and still controversial. To our knowledge, no study has still compared the aetiology of central fatigue (supra-spinal vs. spinal) between children and adults. Only the voluntary activation level had been studied in children, conventionally used to assess central fatigue. But this factor doesn't differentiate spinal and supra-spinal contributions to neuromuscular fatigue development.

The LENGTH-FATIG research project is a physiological and observational study comparing two age groups (adults and children). Subjects will have to perform three randomized fatigue protocols at three muscle lengths (short, optimal and long) with the knee extensors and the ankle plantar flexors.

Data will be analyzed using LabChart 7.3 Pro software (ADInstrument, New South Wales, Australia) and Statistica 8.0 software (StatSoft, Inc.) and significance will be accepted at a two-sided alpha level of p<.05. The normality and homogeneity of the variables will be checked respectively from a Shapiro-Wilk test and a Barlett test.

If normality and homogeneity of the variables are verified, absolute values of variables (Force, EMG, NIRS, etc.) will be compared using three factors (age x muscle length x muscle group) analyses of variance (ANOVA) with repeated measures. If analyses reveal a significant effect of any factor or interaction of factors, post-hoc Newman-Keuls tests will be performed to determine differences between the different conditions.

If, on the contrary, normality and homogeneity of the variables are not verified, the effects of muscle length, muscle group and age will be evaluated using a Friedman test. If the tests show significant effects, comparisons of the different conditions will be performed using Mann-Whitney and Wilcoxon tests.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

50

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Clermont-Ferrand, Francia, 63003
        • Chu Clermont-Ferrand

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 8 anni a 35 anni (Bambino, Adulto)

Accetta volontari sani

Sessi ammissibili allo studio

Maschio

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

prepubertal boys and adults

Descrizione

Inclusion Criteria:

  • Boys aged 8 to 11 years old, Tanner stages 1 to 3
  • Male aged 18 to 35 years old
  • Non-smoker
  • Moderate physical activity level (< 4h/week)
  • Covered by a social health insurance
  • Consent form signed by participants and/or legal guardians.

Exclusion Criteria:

  • Competitive training
  • Cardiac or pulmonary diseases
  • Epileptic seizures past history
  • Magnetic field contraindication (including cardiac valve, pacemaker, prosthesis material, ferro-magnetic foreign body, cochlear implant and ocular prosthesis material.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
knee extensors
The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults
ankle plantar
The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Lasso di tempo
Maximal torque of knee extensors
Lasso di tempo: once a week during six weeks.
once a week during six weeks.
ankle plantar flexors joint (in N.m) measured with a dynamometer.
Lasso di tempo: once a week during six weeks.
once a week during six weeks.

Misure di risultato secondarie

Misura del risultato
Lasso di tempo
Doublet torque amplitude (100Hz, in N.m) evoked using magnetic nerve stimulation at rest
Lasso di tempo: once a week during six weeks.
once a week during six weeks.
Muscular tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy.
Lasso di tempo: once a week during six weeks
once a week during six weeks
Compound muscle action potential amplitude (i.e. M-wave ; in mV) evoked by supramaximal magnetic nerve stimulation and measured by surface Electromyography (EMG).
Lasso di tempo: once a week during six weeks
once a week during six weeks
High frequency doublet (100Hz)/low frequency doublet (10Hz) ratio
Lasso di tempo: once a week during six weeks
once a week during six weeks
fascicule length (mm) measured by B-mode real time ultrasound scanner.
Lasso di tempo: once a week during six weeks
once a week during six weeks
pennation angle (degree) measured by B-mode real time ultrasound scanner.
Lasso di tempo: once a week during six weeks
once a week during six weeks
Voluntary activation level (in %) assessed by using the twitch interpolation technique.
Lasso di tempo: once a week during six weeks
once a week during six weeks
EMG signal Root mean square of EMG signal during isometric maximal voluntary contractions.
Lasso di tempo: once a week during six weeks
once a week during six weeks
Hoffman reflex amplitude (i.e. H-reflex ; in mV) evoked by submaximal magnetic nerve stimulation measured by surface Electromyography (EMG).
Lasso di tempo: once a week during six weeks
once a week during six weeks
Cerebral tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy
Lasso di tempo: once a week during six weeks
once a week during six weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

13 febbraio 2017

Completamento primario (Effettivo)

20 novembre 2017

Completamento dello studio (Effettivo)

20 novembre 2017

Date di iscrizione allo studio

Primo inviato

3 febbraio 2017

Primo inviato che soddisfa i criteri di controllo qualità

9 febbraio 2017

Primo Inserito (Effettivo)

10 febbraio 2017

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

28 novembre 2017

Ultimo aggiornamento inviato che soddisfa i criteri QC

27 novembre 2017

Ultimo verificato

1 novembre 2017

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • CHU-304
  • 2016-A00827-44 (Altro identificatore: 2016-A00827-44)

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su neuromuscular fatigue

3
Sottoscrivi